SetPoint Medical logo — Regulating Inflammation - through the nervous system

SetPoint Medical

Regulating Inflammation - through the nervous system

Founded 2007 United States Valencia, United States 74 employees Venture round Total: $344.00M Biotechnology, Health Care +1

General Information

Company Name SetPoint Medical
Founded Year 2007
Location United States Valencia, United States
Employees 74
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with SetPoint Medical. To contact SetPoint Medical, visit setpointmedical.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does SetPoint Medical compare?

A PDF of SetPoint Medical and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting SetPoint Medical soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About SetPoint Medical

SetPoint Medical is a privately held clinical-stage healthcare company founded in 2007. The company's slogan, "Regulating Inflammation - through the nervous system," reflects its dedication to treating patients with autoimmune diseases. SetPoint Medical operates within the Biotechnology and Health Care industries, and its headquarters is located in the United States. The company has recently secured an $80.00M Venture Round investment on 19 January 2023. The investment was led by a consortium of prominent investors, including New Enterprise Associates, Action Potential VC, Boston Scientific, Citta Ventures, Euclidean Capital, ShangBay Capital, SVE Capital, Gilmartin Capital LLC, and the Richard King Mellon Foundation. SetPoint Medical's focus is on developing a novel platform designed to stimulate the vagus nerve to activate innate anti-inflammatory pathways, thereby producing a systemic immune-restorative effect. This innovative technology offers a promising treatment alternative for conditions such as rheumatoid arthritis, inflammatory bowel disease, and other chronic autoimmune conditions. Importantly, the potential benefits of this platform include potentially less risk and cost than traditional drug therapy. In conclusion, SetPoint Medical's innovative approach to addressing autoimmune diseases, combined with its recent significant investment, positions the company as one to watch in the healthcare and biotechnology sectors.

Business keywords: autoimmune diseases, vagus nerve stimulation, anti-inflammatory, immune-restorative, rheumatoid arthritis, inflammatory bowel disease, chronic conditions, clinical-stage, treatment alternative, innovation, immune system modulation, cost-effective

Funding Rounds & Investors (12)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing $65.00M 1
Runway Growth Capital
19 Jan 2023
Venture Round $80.00M 10
New Enterprise Associates, Norwest Venture Partners +8
19 Jan 2023
Debt Financing $35.00M 1
Runway Growth Capital
13 Jul 2021
Venture Round $64.00M 10
New Enterprise Associates, Morgenthaler Ventures +8
27 Jan 2021
Venture Round $15.70M 6
New Enterprise Associates, Morgenthaler Ventures +4
18 Sep 2019
Series D $30.00M 6
New Enterprise Associates, Morgenthaler Ventures +4
28 Aug 2017
Venture Round Undisclosed 1
New Enterprise Associates
20 Mar 2017
Series C $15.00M 5
Morgenthaler Ventures, Boston Scientific +3
08 Sep 2015
Series C $27.00M 7
Morgenthaler Ventures, Boston Scientific +5
08 Aug 2013
Debt Financing $3.30M -
13 Apr 2012

View All 12 Funding Rounds

SetPoint Medical Alternatives & Competitors

View All Alternatives
SetPoint Medical vs

Analyze | Reset | Revolutionize

Series B
19 employees
Biotechnology, Health Care
SetPoint Medical vs

Multilineage immune modulation. The next chapter in autoimmune diseases.

Seed
3 employees
Health Care, Health and Wellness
SetPoint Medical vs
Xenikos B.V.
Xenikos B.V. The Netherlands

Developing new, innovative immunotherapy medicines that reset the immune system

Grant
1 employees
Biotechnology, Health and Wellness

FAQ About SetPoint Medical

Regulating Inflammation - through the nervous system
SetPoint Medical was founded in 2007.
SetPoint Medical is headquartered in Valencia, United States.
SetPoint Medical operates in Biotechnology, Health Care and Health and Wellness. Its work centres on autoimmune diseases, vagus nerve stimulation, anti-inflammatory and immune-restorative.
SetPoint Medical has approximately 74 employees.
SetPoint Medical has completed 12 funding rounds, raising a total of $344.00M. The latest funding stage is Venture round.
Top alternatives and competitors to SetPoint Medical include Revolo Biotherapeutics, Mysthera Therapeutics, Xenikos B.V., Applied Molecular Transport, Coral (acquihired). These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
SetPoint Medical and Revolo Biotherapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for SetPoint Medical, https://bouncewatch.com/company/setpoint-medical, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes